JTCS Concomitant Website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Article

J Thorac Cardiovasc Surg 2008;135:186-187
© 2008 The American Association for Thoracic Surgery


Evolving Technology

Discussion

The first 20% of the full text of this article appears below.

Dr Eugene H. Blackstone (Cleveland, Ohio). Dr Dewey, I congratulate you and your colleagues on this particularly timely study. Decisions are being made, at least temporarily, about appropriate candidates for early trials of percutaneous AVR. Further, survival after device placement is being compared with that expected were open surgery performed using some of these algorithms. Your study simultaneously addresses the issue of risk stratification to identify the highest risk patients and risk calibration to quantify expected risk. You paint a somewhat disturbing picture.

As an aside, I particularly appreciate your recognizing that early risk does not stop at hospital discharge or even at 30 days, but extends further—in patients with complex problems sometimes many months—a fact that none of these models accounts for explicitly.

Your study is in the same vein as the one recently presented by the Heidelberg group at the European Association. It augments it, however, by looking at three algorithms for risk stratification and expected survival rather than just at the EuroSCORE. Let me highlight three findings of that group, because they lead to a question about your study.

First, in the highest-risk patients, EuroSCORE greatly overestimated risk, just as you have found. This means that expected risk is not well calibrated to actual risk and calls into question not just which patient is at high risk but also any attempt to use estimated risk as a barometer to assess observed risk of alternative procedures.

Second, they found that calibration progressively worsened with era of operation. The EuroSCORE . . . [Full Text of this Article]


Related Article

Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement
Todd M. Dewey, David Brown, William H. Ryan, Morley A. Herbert, Syma L. Prince, and Michael J. Mack
J. Thorac. Cardiovasc. Surg. 2008 135: 180-187. [Abstract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The American Association for Thoracic Surgery.